Singapore markets closed
Straits Times Index
3,303.19 +10.26 (+0.31%) S&P 500
5,156.68 +28.89 (+0.56%) Dow
38,784.81 +109.13 (+0.28%) Nasdaq
16,250.35 +94.02 (+0.58%) Bitcoin USD
63,833.77 -315.45 (-0.49%) CMC Crypto 200
1,374.89 +62.26 (+4.75%)
TFF Pharmaceuticals, Inc. (TFFP)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 09:57AM EDT. Market open.
| Previous close | 2.0300 |
| Open | 2.0500 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 2.0500 - 2.1300 |
| 52-week range | 2.0500 - 19.7500 |
| Volume | |
| Avg. volume | 35,325 |
| Market cap | 5.366M |
| Beta (5Y monthly) | 1.29 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
TFF Pharmaceuticals Full Year 2023 Earnings: Misses Expectations
TFF Pharmaceuticals ( NASDAQ:TFFP ) Full Year 2023 Results Key Financial Results Net loss: US$21.2m (loss narrowed by...
- Insider Monkey
TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Q3 2023 Earnings Call Transcript
TFF Pharmaceuticals, Inc. (NASDAQ:TFFP) Q3 2023 Earnings Call Transcript November 14, 2023 Operator: Good afternoon, ladies and gentlemen, and welcome to the TFF Pharmaceuticals Third Quarter 2023 Corporate Update and Earnings Conference Call. As a reminder, this conference is being recorded. I will now turn the call over to our host, Corey Davis of LifeSci […]
- Zacks
Iovance Biotherapeutics (IOVA) Reports Q2 Loss, Lags Revenue Estimates
Iovance Biotherapeutics (IOVA) delivered earnings and revenue surprises of 41.98% and 96.03%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.